|
|||||
|
|
| 硬斑病病情评估的研究进展 | |
| 引用本文： | 周海燕,吕小岩. 硬斑病病情评估的研究进展[J]. 中国皮肤性病学杂志, 2020, 0(4): 470-472 |
| 作者姓名： | 周海燕 吕小岩 |
| 作者单位： | 四川大学华西医院 |
| 摘 要： | 硬斑病(morphea)是一种引起皮肤和/或深部组织硬化性改变的特发性炎症性皮肤疾病。对硬斑病病情做出准确评估才能制定合理的治疗措施。目前,已经发展出较丰富的评估方法,本文简要综述当前硬斑病的临床评估、仪器评估(例如超声、硬度计、弹性测量仪、肌电图、核磁共振成像)和具有潜在临床应用前景的血清生物标志物。 |
| 关 键 词： | 硬斑病 病情评估 |
The Development in the Evaluation of Morphea |
|
| Affiliation: | (Department of Dermatology,West China Hospital,Sichuan University,Chengdu 610041,China) |
| Abstract: | Morphea is an idiopathic inflammatory skin diseases with cutaneous and/or subcutaneous sclerosis.Accurate assessment of this condition can make reasonable treatment.In recent years,a variety of evaluation methods have been developed.This paper briefly reviewed the current clinical assessment,instrumental evaluation(e.g.,ultrasound,durometer,cutometer,electromyography,MRI) and new serum biomarkers with potential clinical applications. |
| Keywords: | Morphea Evaluation |
| 本文献已被 CNKI 维普 等数据库收录！ | |